 NEW YORK, May 11, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. Adverum or the Company NASDAQ: ADVM. Such investors are advised to contact Robert S. 